Nicolas Chapuis

6.2k total citations
74 papers, 2.7k citations indexed

About

Nicolas Chapuis is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Nicolas Chapuis has authored 74 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 33 papers in Molecular Biology and 15 papers in Genetics. Recurrent topics in Nicolas Chapuis's work include Acute Myeloid Leukemia Research (26 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers). Nicolas Chapuis is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers). Nicolas Chapuis collaborates with scholars based in France, United States and Switzerland. Nicolas Chapuis's co-authors include Didier Bouscary, Jérôme Tamburini, Patrick Mayeux, Lise Willems, Valérie Bardet, Sophie Park, Catherine Lacombe, Alexa S. Green, Norbert Ifrah and François Dreyfus and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nicolas Chapuis

69 papers receiving 2.6k citations

Peers

Countries citing papers authored by Nicolas Chapuis

Since Specialization

Citations

This map shows the geographic impact of Nicolas Chapuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Chapuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Chapuis more than expected).

Fields of papers citing papers by Nicolas Chapuis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Chapuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Chapuis. The network helps show where Nicolas Chapuis may publish in the future.

Co-authorship network of co-authors of Nicolas Chapuis

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Chapuis. A scholar is included among the top collaborators of Nicolas Chapuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Chapuis. Nicolas Chapuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of Machine‐Assisted, Human‐Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes 2025 ·eJHaem ·Kíyoyuki Ogata, (unknown), Leonie Saft, (unknown), (unknown), Canan Alhan, Carole Almire, (unknown), (unknown), Naoko Chiba, (unknown), (unknown), (unknown), (unknown), (unknown), Nicolas Chapuis, Orianne Wagner‐Ballon, Arjan van de Loosdrecht, Yumi Yamamoto	0
2	Enhanced fetal hematopoiesis in response to symptomatic SARS-CoV-2 infection during pregnancy 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Nicolas Chapuis, R Fontaine, Mira El-Khoury, (unknown), (unknown), Aude Jary, Vincent Cálvez, Michaëla Fontenay, Vassilis Tsatsaris, S. Aractingi, Bénédicte Oulès	2
3	Waste heat recovery using thermally responsive ionic liquids through TiO₂ nanopore and macroscopic membranes 2023 ·Energy & Environmental Science ·(unknown), Nicolas Chapuis, (unknown), Marie-Caroline Jullien, Alessandro Siria, Lydéric Bocquet	5
4	Physiopathologie des syndromes myélodysplasiques 2023 ·Bulletin du Cancer ·Michaëla Fontenay, (unknown), Nicolas Chapuis	1
5	ImmunoCluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data 2021 ·eLife ·James W. Opzoomer, (unknown), Kevin Blighe, Thanos P. Mourikis, Nicolas Chapuis, (unknown), (unknown), (unknown), Benedetta Apollonio, Alan G. Ramsay, Mahvash Tavassoli, Claire Harrison, Francesca D. Ciccarelli, Peter J. Parker, Michaëla Fontenay, Paul R. Barber, James N. Arnold, Shahram Kordasti	10
6	Ferroptose et cancer 2021 ·médecine/sciences ·Rudy Birsen, Éric Grignano, Nicolas Chapuis, Didier Bouscary	0
7	Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells 2018 ·Leukemia Research ·Kíyoyuki Ogata, (unknown), Leonie Saft, (unknown), Matteo Giovanni Della Porta, Nicolas Chapuis, Yumi Yamamoto	10
8	Immature/total granulocyte ratio improves early prediction of neurological outcome after out-of-hospital cardiac arrest: the MyeloScore study 2016 ·Annals of Intensive Care ·Bertrand Sauneuf, (unknown), Édouard Cornet, Cédric Daubin, (unknown), Amélie Seguin, Xavier Valette, Nicolas Chapuis, Damien du Cheyron, Jean‐Jacques Parienti, Nicolas Terzi	9
9	Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 2015 ·Haematologica ·Valérie Bardet, Orianne Wagner‐Ballon, Julien Guy, (unknown), Camille Debord, Franck Trimoreau, Emmanuel Benayoun, Nicolas Chapuis, (unknown), Cédric Rossi, Stéphanie Mathis, Marie-Pierre Gourin, Andréa Toma, Marie C. Béné, Jean Feuillard, Estelle Guérin, (unknown)	25
10	Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters 2015 ·Cancer Chemotherapy and Pharmacology ·(unknown), Nicolas Chapuis, George Emile, Anatole Cessot, (unknown), Olivier Huillard, Pascaline Boudou‐Rouquette, Michaëla Fontenay, François Goldwasser, Jérôme Alexandre	8
11	Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes 2013 ·Leukemia ·(unknown), Nicolas Chapuis, Camille Debord, Alexandra Rouquette, I Radford-Weiss, Sophie Park, François Dreyfus, C. Lacombe, Marie C. Béné, Olivier Kosmider, Michaëla Fontenay, Valérie Bardet	58
12	A dramatic fetal outcome following transplacental transfer of dasatinib 2012 ·Anti-Cancer Drugs ·Paul Berveiller, Annalisa Andreoli, Olivier Mir, Olivia Anselem, Anne‐Lise Delezoide, Hélène Sauvageon, Nicolas Chapuis, Vassilis Tsatsaris	39
13	PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies 2012 ·Current Oncology Reports ·Lise Willems, Jérôme Tamburini, Nicolas Chapuis, Catherine Lacombe, Patrick Mayeux, Didier Bouscary	166
14	Sustained Leukemia-Free State and Molecular Response to Sorafenib in a Patient With Chronic Myelomonocytic Leukemia in Transformation Driven by Homozygous FLT3-ITD Malignant Hematopoiesis 2012 ·Clinical Lymphoma Myeloma & Leukemia ·Olivier Kosmider, Nicolas Chapuis, Sophie Kaltenbach, Romain Coriat, (unknown), Lise Willems, Virginie Chesnais, Isabelle Radford‐Weiss, Valérie Bardet, Patrick Mayeux, Jérôme Tamburini, Michaëla Fontenay, Didier Bouscary	3
15	High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study 2011 ·Haematologica ·François Vergez, Alexa S. Green, Jérôme Tamburini, Jean‐Emmanuel Sarry, (unknown), Pascale Cornillet‐Lefèbvre, Mélanie Pannetier, Aymeric Neyret, Nicolas Chapuis, Norbert Ifrah, F. Dreyfus, Stéphane Manenti, Cécile Demur, Éric Delabesse, C. Lacombe, (unknown), Didier Bouscary, Christian Récher, Valérie Bardet	147
16	Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia 2010 ·Clinical Cancer Research ·Nicolas Chapuis, Jérôme Tamburini, Alexa S. Green, Christine Vignon, Valérie Bardet, Aymeric Neyret, Mélanie Pannetier, Lise Willems, Sophie Park, (unknown), Sauveur-Michel Maira, Norbert Ifrah, François Dreyfus, Olivier Hérault, Catherine Lacombe, Patrick Mayeux, Didier Bouscary	128
17	IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia 2010 ·Blood ·Nicolas Chapuis, Sophie Park, Laurent Léotoing, Jérôme Tamburini, Frédèrique Verdier, Valérie Bardet, Alexa S. Green, Lise Willems, Fabrice Agou, Norbert Ifrah, François Dreyfus, Georges Bismuth, Véronique Baud, Catherine Lacombe, Patrick Mayeux, Didier Bouscary	68
18	Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody 2009 ·Haematologica ·Nicolas Chapuis, Jérôme Tamburini, Pascale Cornillet‐Lefèbvre, (unknown), Valérie Bardet, Lise Willems, Sophie Park, Alexa S. Green, Norbert Ifrah, François Dreyfus, Patrick Mayeux, C. Lacombe, Didier Bouscary	113
19	Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia 2009 ·Haematologica ·Sophie Park, Nicolas Chapuis, Jérôme Tamburini, Valérie Bardet, Pascale Cornillet‐Lefèbvre, Lise Willems, Alexa S. Green, Patrick Mayeux, C. Lacombe, Didier Bouscary	236
20	Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients 2007 ·Blood ·Jérôme Tamburini, Caroline Elie, Valérie Bardet, Nicolas Chapuis, Sophie Park, Philippe Broët, Pascale Cornillet‐Lefèbvre, Bruno Lioure, Valérie Ugo, Odile Blanchet, Norbert Ifrah, Francis Witz, François Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact